Most traders aren't short on information. They're short on consistency. One day they stick to their rules. The next day they tweak everything because a few candles looked 'different.' That pattern ...

Management indicated plans to provide both regulatory and clinical trial updates on blarcamesine for indications beyond Alzheimer’s, including Parkinson’s disease, Rett syndrome, and Fragile X.

The European Medicines Agency (EMA) has published a strategy for implementing international guidelines on managing post-approval safety data. EMA’s strategy applies to the first revision of the ...

European authorities have issued an updated strategy for the regulation of drugs in the EU, citing recent advances in manufacturing technology and methods as drivers for the revision. The updated ...